RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dongkook Pharmaceutical Co Stock

Dongkook Pharmaceutical Co Market capitalization 2024

Dongkook Pharmaceutical Co Market capitalization

752.82 B KRW

Ticker

086450.KQ

ISIN

KR7086450004

In 2024, Dongkook Pharmaceutical Co's market cap stood at 752.82 B KRW, a 11.65% increase from the 674.27 B KRW market cap in the previous year.

The Dongkook Pharmaceutical Co Market capitalization history

YEARMarket Capitalization (undefined KRW)
20230.67
20220.93
20211.17
20201.03
20190.58
20180.57
20170.54
20160.55
20150.43
20140.3
20130.29
20120.15

Dongkook Pharmaceutical Co Aktienanalyse

What does Dongkook Pharmaceutical Co do?

Dongkook Pharmaceutical Co Ltd is a South Korean company that specializes in the development and manufacturing of pharmaceutical products. It was founded in 1968 by Choon-kyu Kim, who was working in the research department of Pfizer at the time and wanted to start his own company. During the early years, Dongkook focused on the formulation of drugs and medications manufactured by other companies. In the 1980s, Dongkook expanded its business and started developing and manufacturing its own products. A new facility was also built in Bucheon, a suburb of Seoul, during this time. Production focused on prescription medications, particularly cardiovascular drugs and antidiabetic agents. Dongkook became one of the leading companies in South Korea in this area. In the 1990s, Dongkook continued its expansion and began focusing on the Asian market. New markets were tapped into and partnerships with other pharmaceutical companies were established. In 2000, Dongkook went public, providing additional capital. Today, Dongkook is a globally operating company with a wide portfolio of medications and healthcare products. The company is divided into various business segments, including cardiovascular, diabetes, gastrointestinal, and dermatology. Each of these segments encompasses a wide range of products, from prescription drugs to over-the-counter dietary supplements. In the cardiovascular segment, Dongkook offers pharmaceuticals for the treatment of conditions such as heart failure, hypertension, and angina pectoris. The diabetes segment includes medications for the treatment of type 2 diabetes and other metabolic disorders. In the gastrointestinal segment, Dongkook produces medications for the treatment of stomach and intestinal problems, as well as for supporting the digestive system. In dermatology, the company manufactures medications for the treatment of skin diseases and cosmetic products. An important focus of Dongkook is the research and development of new innovative products. The company has its own research and development department, where work is done on new medications and technologies. Through close collaboration with other companies and research institutions around the world, Dongkook has been able to develop numerous products that are distinguished by their high quality and effectiveness. Dongkook is also committed to promoting sustainable and environmentally friendly business practices. The company is dedicated to the use of renewable energies and continuously works on measures to reduce its environmental impact. Additionally, the company is an active member of the community and supports numerous social initiatives, such as donation campaigns for non-profit organizations, educational programs, and environmental conservation projects. In summary, Dongkook Pharmaceutical Co Ltd is a leading global pharmaceutical company known for its innovation, product quality, and sustainable business practices. With a wide portfolio of medications and healthcare products, as well as a strong research and development department, the company is well-positioned for the future and will continue to play an important role in the pharmaceutical industry. Dongkook Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Dongkook Pharmaceutical Co's Market Capitalization

Dongkook Pharmaceutical Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Dongkook Pharmaceutical Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Dongkook Pharmaceutical Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Dongkook Pharmaceutical Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Dongkook Pharmaceutical Co stock

What is the current Dongkook Pharmaceutical Co market capitalization?

The current market capitalization of Dongkook Pharmaceutical Co is 752.82 B KRW.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Dongkook Pharmaceutical Co.

How has the market capitalization of Dongkook Pharmaceutical Co developed in recent years?

The market capitalization of Dongkook Pharmaceutical Co has increased/decreased by 11.65% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Dongkook Pharmaceutical Co?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Dongkook Pharmaceutical Co?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Dongkook Pharmaceutical Co have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Dongkook Pharmaceutical Co pay?

Over the past 12 months, Dongkook Pharmaceutical Co paid a dividend of 180 KRW . This corresponds to a dividend yield of about 1.07 %. For the coming 12 months, Dongkook Pharmaceutical Co is expected to pay a dividend of 196.06 KRW.

What is the dividend yield of Dongkook Pharmaceutical Co?

The current dividend yield of Dongkook Pharmaceutical Co is 1.07 %.

When does Dongkook Pharmaceutical Co pay dividends?

Dongkook Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Dongkook Pharmaceutical Co?

Dongkook Pharmaceutical Co paid dividends every year for the past 15 years.

What is the dividend of Dongkook Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 196.06 KRW are expected. This corresponds to a dividend yield of 1.16 %.

In which sector is Dongkook Pharmaceutical Co located?

Dongkook Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dongkook Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dongkook Pharmaceutical Co from 4/19/2024 amounting to 180 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Dongkook Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 4/19/2024.

What was the dividend of Dongkook Pharmaceutical Co in the year 2023?

In the year 2023, Dongkook Pharmaceutical Co distributed 180 KRW as dividends.

In which currency does Dongkook Pharmaceutical Co pay out the dividend?

The dividends of Dongkook Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dongkook Pharmaceutical Co

Our stock analysis for Dongkook Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dongkook Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.